The findings presented here align with the mechanism of action of Amblyomin-X, which induces mitochondrial damage through disruption of the BCL-2 family, leading to reactive oxygen species (ROS) generation and caspase activation in renal carcinoma cells [10]. Here, BCL2 is linked to renal carcinoma.